Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

David Parks

Internal Medicine St Louis, MO Medical Doctor

NPI 1649315219 CMS profile 301710

3960 Lindell Blvd, St Louis, MO 63108

Open in the dashboard

General payments

$50,392

144 records reported · program years 2019–2021

Research payments

$878

Paid to them · 10 records reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$172,509 paid to institutions, not to them · program years 2019–2023

Through program year 2021, David Parks of St Louis, MO is reported in the CMS Open Payments database as having received $50,392 across 144 general payments and $878 in research payments paid to them. Separately, studies naming them as principal investigator received $172,509 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $1,521 21
2020 General $6,985 31
2019 General $41,886 92
2019 Research $878 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Parks
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to David Parks were reported at $0. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year David Parks Internal Medicine median Middle half National median
2019 $41,886 $159 $48–$570 $163
2020 $6,985 $119 $33–$402 $114
2021 $1,521 $135 $37–$521 $132
2022 $0 $141 $42–$496 $149
2023 $0 $149 $45–$519 $160
2024 $0 $154 $47–$537 $164
2025 $0 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. Gilead Sciences, Inc. $37,804 87 payments
  2. ViiV Healthcare Company $11,215 26 payments
  3. Theratechnologies Inc. $843 3 payments
  4. Merck Sharp & Dohme Corporation $204 11 payments
  5. Janssen Products, LP $100 1 payment
  6. EMD Serono, Inc. $89 4 payments
  7. Janssen Biotech, Inc. $50 5 payments
  8. Salix Pharmaceuticals, a division of Bausch Health US, LLC $28 2 payments
  9. Amgen Inc. $23 2 payments
  10. Vyera Pharmaceuticals, LLC $16 1 payment
  11. Other $20 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $27,385 14 payments
  2. Consulting Fee $12,110 3 payments
  3. Travel and Lodging $8,024 30 payments
  4. Food and Beverage $2,018 94 payments
  5. Honoraria $750 1 payment
  6. Education $105 2 payments
Products named General payments · program years 2019–2021
  1. Biktarvy $11,723 16 payments
  2. Truvada $10,446 14 payments
  3. Descovy $8,367 11 payments
  4. TROGARZO $843 3 payments
  5. DELSTRIGO $173 9 payments
  6. SYMTUZA $149 6 payments
  7. PIFELTRO $141 7 payments
  8. ISENTRESS $141 7 payments
  9. DOVATO $124 7 payments
  10. DIFICID $86 4 payments
  11. Other $339 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2021
  1. ViiV Healthcare Company $878 10 payments

Records

154 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record